SCHEMBL2053272

SCHEMBL2053272

Cc1csc(-c2ccnn2C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 1/20 0.41
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP2 O95551 2/20 0.38
MAPT P10636 1/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PI4KA P42356 1/20 0.37
PIK3CG P48736 1/20 0.37
PI4KB Q9UBF8 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
GRIN1 Q05586 2/20 0.34
GRIN2B Q13224 2/20 0.34
GABRA1 P14867 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2053197 0.79 NR3C2 (0.42) TDP2GRIN1GRIN2BGABRA1GABRG2
SCHEMBL2052712 0.78 NR3C2 (0.40) ALDH1A1TDP2GRIN1GRIN2BGABRA1
SCHEMBL2050668 0.78 GRIN2B (0.38) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL14103218 0.77 COMT (0.37) COMTALDH1A1KDM4ENPC1LMNA
SCHEMBL937627 0.76 DAO (0.42) COMTALDH1A1MAPTCTSA
SCHEMBL2053415 0.73 L3MBTL1 (0.41) ALDH1A1KDM4EGRIN1GRIN2B
SCHEMBL938518 0.72 MEN1 (0.41) ALDH1A1KDM4ELMNASMN1; SMN2MAPT
SCHEMBL15950989 0.71 COMT (0.60) COMTALDH1A1KDM4ENPC1LMNA
SCHEMBL10475743 0.70 KDM4E (0.50) COMTALDH1A1KDM4ENPC1LMNA
SCHEMBL18483005 0.69 COMT (0.46) COMTALDH1A1KDM4ENPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516423-A1 THIENYLPYRI (MI) DINYLAZOLE AND THEIR USE FOR CONTROLLING PHYTOPATHOGENIC FUNGI Bayer CropScience AG (DE) 2012-10-31 EP disclosed
CN-102762551-A Thienylpyri (mi) dinylpyrazoles and their use for controlling phytopathogenic fungi BAYER CROPSCIENCE AG 2012-10-31 CN disclosed
US-20110237588-A1 Thienylpyri(mi)dinylazole BAYER CROPSCIENCE AG (DE) 2011-09-29 US disclosed
WO-2011076725-A1 THIENYLPYRI (MI) DINYLAZOLE AND THEIR USE FOR CONTROLLING PHYTOPATHOGENIC FUNGI BAYER CROPSCIENCE AG (DE) 2011-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237588-A1 Thienylpyri(mi)dinylazole PADI1, TH, H1-3 COMT 3881/4885ALDH1A1 1184/4885KDM4E 2907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.